Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-10-06 | Geoffrey E. Harris joined our Board of Directors on July 30, 2015. Mr. Harris is a portfolio manager and managing partner at c7 Advisors, a money management and healthcare advisory firm focused on small-to-middle market healthcare companies. Mr. Harris was selected to serve on our Board of Directors for his significant healthcare, finance and transactional experience. Furthermore, his financial, analytical and audit committee experience make him well suited to Chair our Audit Committee. The following table below sets forth the membership of each Committee: Geoffrey Harris Chair Audit Committee. |
| 2016-10-06 | Geoffrey E. Harris joined our Board of Directors on July 30, 2015. ... Mr. Harris joined our Board on July 20, 2015. ... The following table ... Geoffrey Harris 2016 Option Awards 132,700 Stock Awards - Total 132,700 |
| 2017-07-27 | Geoffrey E. Harris joined our Board of Directors on July 30, 2015. Mr. Harris is a portfolio manager and managing partner at c7 Advisors... Mr. Harris serves as a director on the boards of Cancer Genetics, Inc. and two privately held companies... Mr. Harris also serves on the Audit Committee of Cancer Genetics, Inc. Mr. Harris was selected to serve on our Board of Directors for his significant healthcare, finance and transactional experience. Furthermore, his financial, analytical and audit committee experience make him well suited to Chair our Audit Committee... The audit committee is composed of members who are "independent" within the meaning of Rule 10A-3 under the Exchange Act and the NASDAQ Stock Market Rules. Mr. Harris (Chair), Mr. Pappajohn and Mr. Votruba are the members of the audit committee... Our compensation committee assists the Board of Directors in the discharge of its responsibilities relating to the compensation of the Board of Directors and our executive officers. Mr. Pappajohn (Chair), Mr. Harris and Mr. Votruba are the members of our compensation committee... Mr. Harris joined our Board on July 20, 2015... During our fiscal year ended September 30, 2016, non-employee directors did not receive any cash compensation but did receive fully vested grants of Common Stock, Restricted Stock and options to purchase Common Stock for their service on our Board of Directors or committees thereof... Geoffrey Harris Option Awards ($) 132,700, Stock Awards ($) 0, Total ($) 132,700. |
| 2018-03-01 | Geoffrey E. Harris joined our Board of Directors on July 30, 2015. Mr. Harris is a portfolio manager and managing partner at c7 Advisors... Mr. Harris serves as a director on the boards of Cancer Genetics, Inc. and two privately held companies... Mr. Harris also serves on the Audit Committee of Cancer Genetics, Inc. Mr. Harris was selected to serve on our Board for his significant healthcare, finance and transactional experience... Board Committees: Audit Committee: Geoffrey Harris (Chair), John Pappajohn, and Michal Votruba... Compensation Committee: John Pappajohn (Chair), Geoffrey Harris and Peter Unanue... Governance and Nominations Committee: Michal Votruba (Chair), John Pappajohn, and Geoffrey Harris... Director Compensation―Fiscal Year Ended September 30, 2017: Geoffrey Harris Fees Earned or Paid in Cash ($) 544 Option Awards ($) 63,540 Stock Awards ($) 64,800 Total ($) 128,884. |
| 2018-11-02 | Geoffrey Harris (3) 25,000 Fees Earned or Paid in Cash, — Option Awards ($), 10,215 Stock Awards ($), Total ($) 35,215 |
Data sourced from SEC filings. Last updated: 2025-12-06